ENOCHIAN BIOSCIENCES
Enochian BioSciences is a biotechnology company focusing on VIVA, a Phase III clinical trial for our lead candidate MCV. MCV is an adjuvant immunotherapy that is designed to prevent colon cancer recurrence after standard of care surgery and chemotherapy. MCV, a dendritic cell cancer vaccine, can be used in several solid tumors either as a standalone adjuvant therapy or in combination with checkpoint inhibitors. Our expertise in producing dendritic cells from a patient's blood is combined with conventional production methods with a goal of making new and advanced vaccines for cancer patients.
ENOCHIAN BIOSCIENCES
Industry:
Biotechnology Health Care Medical Device
Founded:
2011-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.enochianbio.com
Total Employee:
1+
Status:
Active
Total Funding:
48 M USD
Technology used in webpage:
Team.blue
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-02-19 | Enochian Biopharma | Enochian Biopharma acquired by Enochian BioSciences | N/A |
| 2016-04-05 | OncoSynergy | OncoSynergy acquired by Enochian BioSciences | N/A |
Key Employee Changes
Official Site Inspections
http://www.enochianbio.com Semrush global rank: 4.22 M Semrush visits lastest month: 2.79 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Enochian BioSciences"
Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief …
Jul 20, 2021 Dr. Dybul’s Deep and Prestigious Scientific Research Expertise Helps to Affirm Enochian BioSciences’ Scientific ApproachLOS ANGELES, July 20, 2021 (GLOBE …See details»
Enochian BioSciences Company Profile | Management and
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human …See details»
Enochian BioSciences - Crunchbase Company Profile & Funding
Enochian BioSciences is a biotechnology company focusing on VIVA, a Phase III clinical trial for our lead candidate MCV. MCV is an adjuvant immunotherapy that is designed to prevent colon …See details»
Renovaro BioSciences Inc. (NASDAQ: RENB) Aims to
Aug 25, 2023 Renovaro’s current product development pipeline includes a variety of treatment candidates spanning cancer, HIV, and HBV; Renovaro’s Pre-Investigational New Drug (pre …See details»
Enochian BioSciences Announces the Successful Completion of an …
Oct 18, 2021 About Enochian BioSciences, Inc. Enochian BioSciences, Inc. is a biopharmaceutical company focused on developing innovative platforms for gene-modified …See details»
Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief
Jul 20, 2021 Under Mark’s leadership, we are excited to see the organization rapidly advance toward its goal of developing cures for HBV, HIV and potentially, to address inhaled pan …See details»
Enochian BioSciences | VentureRadar
Website: https://enochianbio.com/ Develops gene-modified cell therapies for applications in HIV/AIDS, HBV, and oncology, focusing on identification, development ...See details»
How Does Enochian BioSciences Work? - CBM
Enochian BioSciences is a pioneering biotechnology company that operates at the intersection of innovation and profitability. Founded on cutting-edge research and a commitment to …See details»
Enochian Biosciences
Nov 15, 2024 We value your privacy. We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you …See details»
Enochian Biosciences, Inc. - Cruelty Free Investing
Company Website: https://enochianbio.com Contact: [email protected]‌ ©2024 CrueltyFreeInvesting.org | Cruelty Free Investing is a registered 501c3 Non-Profit Organization …See details»
Enochian BioSciences Announces that its Cancer Platform Remains …
LOS ANGELES, June 08, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB). Enochian BioSciences Inc. (the Company) announces that it remains confident in submitting an …See details»
Enochian Biosciences aka DanDrit Biotech | CipherBio
Explore Enochian Biosciences aka DanDrit Biotech's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Enochian BioSciences - VentureRadar
Open PageRank: 4,280,386 | enochianbio.com. VentureRadar Popularity. Medium. VentureRadar Popularity: Medium. The popularity score combines profile views, clicks and the number of …See details»
Enochian BioSciences Announces Acquisition of Exclusive License …
Jun 21, 2021 For more information, please visit Enochianbio.com About Seraph Research Institute (SRI) Seraph Research Institute is a Los Angeles-based non-profit research …See details»
Enochian BioSciences Announces Acquisition of Exclusive License …
Jun 21, 2021 Request for Pre-Investigator New Drug Meeting to Be Submitted to FDA in Near TermLOS ANGELES, June 21, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian …See details»
Enochian BioSciences Announces the Appointment of Executive …
LOS ANGELES, April 20, 2022 (GLOBE NEWSWIRE) -- Enochian BioSciences (NASDAQ: ENOB). Enochian BioSciences Inc., a company focused on gene-modified cellular and …See details»
Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief
Jul 20, 2021 For more information, please visit Enochianbio.com. Forward-Looking Statements Statements in this press release that are not strictly historical in nature are forward-looking …See details»
Enochian BioSciences Announces Its Successful Completion
Sep 27, 2021 Enochian BioSciences, Inc. is a biopharmaceutical company focused on developing innovative platforms for gene-modified cellular and immune therapies to potentially …See details»
Enochian BioSciences Announces Scientific Presentation at World …
LOS ANGELES, Dec. 03, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in …See details»
Enochian BioSciences Announces Scientific Presentation of …
Jun 30, 2021 Enochian BioSciences holds the exclusive license for the proprietary technology. The daily measurements, studies of various doses of the product, and toxicity are important …See details»